Le Lézard
Classified in: Mining industry, Ebola virus, Transportation
Subject: CCA

SKF's first quarter results to be published on 26 April


GOTHENBURG, Sweden, April 12, 2024 /PRNewswire/ -- SKF will publish its first quarter results for 2024 on 26 April 2024 at approximately 07:00 (CEST).

Investors, analysts and media are invited to join a webcast, which will be held in English, at 08:00 (CEST).

To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers.

Link to web event: https://www.investis-live.com/skf/660bf9a11feb820d001f1ad6/jsret

Sweden                           +46 8 5051 0031
UK / International            +44 20 7107 0613
Passcode:                       43658997

All information regarding the results will be made available on the Group's IR website:
https://investors.skf.com/en/reports-and-presentations

Media: To book interviews with Rickard Gustafson, President and CEO, or Niclas Rosenlew, CFO, after the webcast, please contact Carl Bjernstam on [email protected].

Aktiebolaget SKF
     (publ)

For further information, please contact:
PRESS: Carl Bjernstam, Head of Media Relations
tel: 46 31-337 2517; mobile: 46 722-201 893; e-mail: [email protected]

INVESTOR RELATIONS: Sophie Arnius, Head of Investor Relations
tel: 46 31-337 8072; mobile: 46 705-908 072; [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skf/r/skf-s-first-quarter-results-to-be-published-on-26-april,c3960411

The following files are available for download:

https://mb.cision.com/Main/637/3960411/2727168.pdf

20240412 SKF's first quarter results to be published on 26 April

 

SOURCE SKF


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: